Search clinical trials for: TACE combined with lenvatinib and iodion-125 seeds brachytherapy

Total 101 results

Second Affiliated Hospital of Guangzhou Medical...

Recruiting

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Hepatocellular Carcinoma Non-resectable

China
New York Presbyterian Brooklyn Methodist Hospital

Completed

Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds

Prostate Cancer
Jiangxi Provincial Cancer Hospital

Completed

Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients

Thyroid Neoplasms

China
British Columbia Cancer Agency
Biocompatibles UK Ltd

Completed

Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate (FAST)

Prostate Cancer

Canada
Second Affiliated Hospital of Guangzhou Medical...
Sun Yat-sen University; Guangdong Provincial People's Hospital; Third Affiliated... and other collaborators

Active, not recruiting

TACE Combined With Iodine-125 Seeds Implantation for HCC

Hepatocellular Carcinoma | Portal Vein Occlusion | Tumor Thrombus

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Hepatocellular Carcinoma Non-resectable

China
Third Affiliated Hospital, Sun Yat-Sen University
Sun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Second... and other collaborators

Not yet recruiting

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Tumor Thrombus
Sichuan University

Not yet recruiting

The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC

Carrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular Carcinoma

China
Second Affiliated Hospital of Guangzhou Medical...

Completed

TACE Combined With Lenvatinib and Sintilimab for Advanced HCC

Hepatocellular Carcinoma Non-resectable

China
CHU de Quebec-Universite Laval
Sunnybrook Health Sciences Centre; Université de Montréal

Completed

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer (HDRvsLDR)

Prostate Cancer

Canada
Peking University Third Hospital

Recruiting

3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors

Malignant Tumor of Head and/or Neck

China
Peking University Third Hospital

Recruiting

RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT

Chest Wall Tumor

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma

Objective Response Rate (ORR)
Sun Yat-sen University

Recruiting

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Liver Tumor

China
Jiangxi Provincial Cancer Hospital

Completed

Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer

Thyroid Neoplasms
Translational Research Center for Medical Innovation...
Kurosawa Hospital

Completed

Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer (J-POPS)

Prostate Cancer

Japan
Tianjin Medical University Cancer Institute and...

Unknown

PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC (PLTHCC)

Hepatocellular Carcinoma Non-resectable

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Prostate Cancer

United States, Canada
Peking University Third Hospital

Not yet recruiting

AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer

Cervical Cancer
Wen Tianfu

Recruiting

Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)

Advanced Hepatocellular Carcinoma

China
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
CHU de Quebec-Universite Laval

Recruiting

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Prostate Cancer

Canada
Zhejiang Cancer Hospital

Recruiting

Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors

Hepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | Pharmorubicin

China
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC

Advanced Hepatocellular Carcinoma (HCC)

Italy, Poland, Singapore, United States, China, Ukraine
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI)

Completed

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Brain and Central Nervous System Tumors

United States
The Second People's Hospital of GuangDong Province

Completed

Hepatocellular Carcinoma Treated With Iodine-125 Implantation

Liver Carcinoma
Zhongda Hospital

Unknown

A Trail of a Novel Tracheal Radioactive Stent for the Malignant Airway Obstruction

Malignant Airway Obstruction

China
Stanford University

Terminated

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast Cancer

United States
Peking University Third Hospital
Shengli Oilfield Central Hospital; First Affiliated Hospital of the Army Medical...

Completed

CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors

Desmoid Tumor | Brachytherapy | Radioactive Iodine-125 Seed Implantation

China
Shanghai Zhongshan Hospital

Active, not recruiting

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma, Intrahepatic

China
Shanghai Zhongshan Hospital
The First Affiliated Hospital with Nanjing Medical University; Changhai Hospital and other collaborators

Unknown

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Hepatocellular Carcinoma | Portal Vein Tumor Thrombus

China
Shanghai Zhongshan Hospital

Recruiting

A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC

Hepatocellular Carcinoma | Donafenib

China
Sun Yat-sen University
Ministry of Health, China

Unknown

Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion (MDTforHCC)

Hepatocellular Carcinoma

China
University Hospital, Grenoble
Clinical Investigation Centre for Innovative Technology Network; Koelis

Recruiting

Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System (FOCUS-BOOST)

Prostate Cancer

France
Università Vita-Salute San Raffaele

Recruiting

Restoring Neural Oscillatory Communication in Developmental Dyslexia

Developmental Dyslexia

Italy
Guangxi Medical University

Completed

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC (FRONT-1)

Liver Cancer

China
Translational Research Center for Medical Innovation...
The Jikei University School of Medicine

Completed

Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer (SHIP0804)

Prostate Cancer

Japan
Sun Yat-sen University

Recruiting

Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC (TALENT)

Recurrent Hepatocellular Carcinoma

China
Peking University Third Hospital

Completed

The Physical Dosimetry Study and Preliminary Clinical Results of 3D-printing Non Co-planar Template Assisted With CT-guidance for Iodine-125 Seed Brachytherapy in Pelvic Recurrent Rectum Carcinoma After Surgery and External Beam Radiotherapy

Rectum Cancer, Recurrent | Brachytherapy, Radioisotope
Stanford University

Withdrawn

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

Thyroid Cancer
Peking University Third Hospital

Not yet recruiting

Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma

Cervical Squamous Cell Carcinoma

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Resectable Hepatocellular Carcinoma

China
Shanghai Zhongshan Hospital
Shanghai Municipal Science and Technology Commission

Withdrawn

Combination Treatment for Advanced Liver Cancer

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion

China
Sun Yat-sen University

Recruiting

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

Clear Cell Renal Cell Carcinoma | Neoadjuvant Therapy | Cadonilimab

China
Sun Yat-sen University

Not yet recruiting

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Renal Cell Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Cervical Cancer

China
Sherief Abd-Elsalam
Tanta University

Recruiting

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma

Liver Cancer

Egypt
Tongji Hospital

Recruiting

A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICC (CCGLC-005)

Intrahepatic Cholangiocarcinoma

China
Hunan Province Tumor Hospital

Recruiting

JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer

Small-cell Lung Cancer

China
Zhongda Hospital

Completed

IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction (IRCSMBO)

Malignant Biliary Obstruction

China

Search clinical trials for: TACE combined with lenvatinib and iodion-125 seeds brachytherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations